Sustained viral response in patients with hepatitis C and chronic kidney disease in hemodialysis and treatment with direct acting antivirals in the UMAE 71

Sustained viral response in patients with hepatitis C and chronic kidney disease in hemodialysis and treatment with direct acting antivirals in the UMAE 71

Bibliographic Details
Main Authors:	E.A. Jasso-Baltazar, F.A. Solís-Galindo, M.A. Muñoz-Hernández
Format:	Article
Language:	English
Published:	Elsevier 2020-09-01
Series:	Annals of Hepatology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1665268120301058

Similar Items

Management of hepatitis C viral infection in chronic kidney disease patients on hemodialysis in the era of direct-acting antivirals
by: Soon Young Ko, et al.
Published: (2018-12-01)

Direct Acting Antivirals for the Treatment of Chronic Viral Hepatitis
by: Peter Karayiannis
Published: (2012-01-01)

Mechanisms of Hepatitis C Viral Resistance to Direct Acting Antivirals
by: Asma Ahmed, et al.
Published: (2015-12-01)

Treatment of chronic viral hepatitis C with direct acting antiviral agent: review
by: V A Malov, et al.
Published: (2019-11-01)

Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis
by: Po-Yao Hsu, et al.
Published: (2021-01-01)

Direct-acting antivirals for the treatment of chronic hepatitis C in patients with chronic kidney disease
by: Anita Kohli, et al.
Published: (2016-11-01)

Mexican experience with direct-acting antivirals in the treatment of hepatitis C
by: J.L. Pérez Hernández, et al.
Published: (2020-09-01)

Safety and efficacy of direct-acting antivirals for chronic hepatitis C in patients with chronic kidney disease
by: Elena Laura Iliescu, et al.
Published: (2020-01-01)

A viral dynamic model for treatment regimens with direct-acting antivirals for chronic hepatitis C infection.
by: Bambang S Adiwijaya, et al.
Published: (2012-01-01)

Efficacy of direct-acting antiviral therapy for hepatitis C viral infection. Real-life experience in Bahrain
by: Abdulla M, et al.
Published: (2019-05-01)

New treatment of hepatitis C (Direct Acting Antiviral)
by: Mohsen Akhondi-Meybodi
Published: (2019-10-01)

Changes in hepatic fibrosis and vitamin D levels after viral hepatitis C eradication using direct-acting antiviral therapy
by: Supachaya Sriphoosanaphan, et al.
Published: (2020-10-01)

Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection.
by: Ming V Lin, et al.
Published: (2016-01-01)

Interactions between Immunosuppressive Therapy and Direct-Acting Antivirals in Kidney Transplant Recipient with Hepatitis C Infection
by: Paolo Carta, et al.
Published: (2020-05-01)

The long-term impact of hepatitis C infection in kidney transplantation in the pre-direct acting antiviral era
by: Radhika Chemmangattu Radhakrishnan, et al.
Published: (2018-01-01)

Effectiveness of direct-acting antivirals in Hepatitis C virus infection in haemodialysis patients
by: Soraya Abad, et al.
Published: (2017-03-01)

Partial restoration of immune response in Hepatitis C patients after viral clearance by direct-acting antiviral therapy.
by: Meritxell Llorens-Revull, et al.
Published: (2021-01-01)

Eradication of hepatitis C virus infection in kidney transplant recipients using direct‐acting antiviral therapy: Qatar experience
by: Mohamad M. Alkadi, et al.
Published: (2021-03-01)

Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus
by: Tavares RCF, et al.
Published: (2018-10-01)

Refractory Hepatic Hydrothorax in Chronic Hepatitis C Controlled by Direct-acting Antivirals
by: Myung Hee Kim, et al.
Published: (2020-02-01)

Hepatocellular carcinoma after direct-acting antiviral therapy in kidney transplant recipients infected with hepatitis C virus
by: Rita Calça, et al.
Published: (2020-11-01)

Hepatocellular carcinoma after direct-acting antiviral therapy in kidney transplant recipients infected with hepatitis C virus
by: Rita Calça, et al.
Published: (2020-11-01)

Visualization of Positive and Negative Sense Viral RNA for Probing the Mechanism of Direct-Acting Antivirals against Hepatitis C Virus
by: Dandan Liu, et al.
Published: (2019-11-01)

Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus [Erratum]
by: Tavares RCF, et al.
Published: (2018-12-01)

Direct Acting Antivirals in Hepatitis C-Infected Kidney Transplant Recipients: Associations with Long-term Graft Failure and Patient Mortality
by: Michael R Goetsch, et al.
Published: (2020-09-01)

Hepatitis C virus-associated membranoproliferative glomerulonephritis treated with directly acting antiviral therapy
by: S Nayak, et al.
Published: (2018-01-01)

Underutilization of Hepatitis C Virus Seropositive Donor Kidneys in the United States in the Current Opioid Epidemic and Direct-Acting Antiviral Era
by: Andrew A. Li, et al.
Published: (2018-07-01)

Bioequivalent pharmacokinetics for generic and originator hepatitis C direct-acting antivirals
by: Andrew Hill, et al.
Published: (2018-04-01)

Hepatitis C virus, directly acting antivirals and Guillain-Barré syndrome
by: Manish Balwani, et al.
Published: (2018-01-01)

Incidence of depression in patients with hepatitis C treated with direct-acting antivirals
by: Elfi Egmond, et al.

Direct Acting Antivirals in Patients with Chronic Hepatitis C and Down Syndrome
by: Eric R. Yoo, et al.
Published: (2016-01-01)

Discovery and evaluation of direct acting antivirals against hepatitis C virus
by: Abdurakhmanov, Eldar
Published: (2015)

Effects of Age on Treatment of Chronic Hepatitis C with Direct Acting Antivirals
by: Alexandre Pariente, et al.
Published: (2019-01-01)

The Direct-Acting Antivirals for Hepatitis C Virus and the Risk for Hepatocellular Carcinoma
by: Paulina Chinchilla-López, et al.
Published: (2017-05-01)

The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C
by: Irina RUSU, et al.
Published: (2020-03-01)

Efficacy and safety of direct-acting antivirals for treatment of hepatitis C infected kidney transplant recipients; a meta-analysis
by: Wisit Cheungpasitporn, et al.
Published: (2017-04-01)

Assessment of serum Resistin in detecting Insulin Resistance and their impact on response to direct acting antiviral in chronic viral hepatitis C patients
by: Amira Isaac, et al.
Published: (2021-08-01)

Prognosis of late elderly patients with chronic hepatitis C after achieving a sustained viral response by direct‐acting antivirals
by: Satoshi Takakusagi, et al.
Published: (2021-01-01)

Predicting Early Viral Control under Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus Using Pretreatment Immunological Markers
by: James A. Hutchinson, et al.
Published: (2018-02-01)

Effectiveness of direct-acting antiviral drugs against hepatitis C virus: predictive factors of response to the treatment
by: María E. Cárdaba-García, et al.
Published: (2021-01-01)